Pneumonic vs Nonpneumonic Acute Exacerbations of COPD

Study objective To describe and compare the background, clinical manifestations, disease course, and infectious etiologies of pneumonic acute exacerbations (PNAE) vs nonpneumonic acute exacerbations (NPAE) of COPD. Design A prospective, observational study. Setting A tertiary university medical center in southern Israel. Patients Twenty-three hospitalizations for PNAE and 217 hospitalizations for NPAE were included in the study. Paired sera were obtained for each of the hospitalizations and were tested serologically for 12 pathogens. Only a significant change in antibody titers or levels was considered diagnostic. Results No significant differences were found between the two groups for any of the parameters related to COPD or comorbidity. The clinical type of the exacerbation was not significantly different between the groups. Compared to NPAE, patients with PNAE had lower Po 2 values at hospital admission (p = 0.004) but higher rates of abrupt onset (p = 0.005), ICU admissions (p = 0.006), invasive mechanical ventilation (p = 0.01), mortality (p = 0.007), and longer hospital stay (p = 0.001). In 22 PNAE hospitalizations (96%) and in 153 NPAE hospitalizations (71%), at least one infectious etiology was identified (p = 0.001). Mixed infection was found in 13 patients with PNAE (59%) and in 59 patients with NPAE (39%; not significant [NS]). Viral etiology was identified in 18 patients with PNAE (78%) compared with 99 patients with NPAE (46%; p = 0.003). Pneumococcal etiology was found in 10 patients with PNAE (43%) and in 38 patients with NPAE (18%; p = 0.006). An atypical etiology was identified in 8 patients with PNAE (35%) and 64 patients with NPAE (30%; NS). Conclusions Community-acquired pneumonia is common among patients hospitalized for an acute exacerbation of COPD and is generally manifested by more severe clinical and laboratory parameters. In PNAE, compared to NPAE, viral and pneumococcal etiologies are more common, but the rate of atypical pathogens is similar. The therapeutic significance of these findings should be investigated further.

[1]  A. Jones,et al.  NO: COPD and beyond , 1997, Thorax.

[2]  T. Murphy,et al.  Analysis of Antigenic Structure and Human Immune Response to Outer Membrane Protein CD of Moraxella catarrhalis , 1999, Infection and Immunity.

[3]  S. Liu,et al.  [Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease]. , 2001, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[4]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[5]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[6]  D. Lieberman,et al.  Atypical pathogens in community-acquired pneumonia. , 1999, Clinics in chest medicine.

[7]  M. Leinonen,et al.  Infectious etiologies in acute exacerbation of COPD. , 2001, Diagnostic microbiology and infectious disease.

[8]  M. Woodhead,et al.  Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[9]  A. Buist.  Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[10]  J. Wedzicha,et al.  Exacerbations of chronic obstructive pulmonary disease. , 2003, Respiratory care.

[11]  E. Walsh,et al.  Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[12]  V. Snow,et al.  Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2001, Annals of Internal Medicine.

[13]  E. Manor,et al.  Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. , 1996, Thorax.

[14]  J. Serra,et al.  Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. , 1996, American journal of respiratory and critical care medicine.

[15]  T. Marrie,et al.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.

[16]  J. A. Cuello,et al.  Severe community-acquired pneumonia. Etiology, prognosis, and treatment. , 1990, The American review of respiratory disease.

[17]  T. Murphy,et al.  Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. , 1997, The Journal of infectious diseases.

[18]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[19]  R. Rodríguez-Roisín,et al.  Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.

[20]  M. Cosio,et al.  Current and future management of acute exacerbations of chronic obstructive pulmonary disease , 1999 .

[21]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[22]  M. Niederman,et al.  Acute exacerbation of COPD: factors associated with poor treatment outcome. , 2000, Chest.

[23]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[24]  M. Wysocki,et al.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. , 1995, The New England journal of medicine.

[25]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.

[26]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.